The 5th "Growing Up Without Cancer & National Assembly" symposium dedicated to the fight against childhood cancers and serious illnesses, which took place on Wednesday February 16, 2022, once again mobilized dozens of deputies, associations, researchers, professionals (health, social workers, teachers) and families. Back to the highlights...
Pediatric cancer research
- Review of projects supported in 2021 with 5M€/year . The calls for projects created by INCa are innovative, new teams are supported, researchers have great ideas, but the budget slider was too low to support all the good projects. In addition, several actions remain to be started or reinforced, particularly in terms of research into the causes of pediatric cancers and prevention.
- Pharmaceutical manufacturers: unacceptable brakes . Dr. Christophe Grosset, Research Director at INSERM Bordeaux, spoke of the refusal of a major drug manufacturer to communicate any information relating to a treatment which demonstrates, in combination with a statin, its effectiveness in the laboratory in the fight against brainstem tumors.
The survival rate for this childhood-specific cancer is disastrous: less than 1% survival over 5 years. This refusal blocks the development of a clinical trial, while several oncologists are applicants. A common mobilization begins.